Price T Rowe Associates Inc Selecta Biosciences Inc Transaction History

Price T Rowe Associates Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.67 - $1.35 $2,267 - $4,568	3,384 Added 14.31%	27,039 $19,000
Q3 2023 Nov 14, 2023	SELL	$1.02 - $1.23 $22,246 - $26,826	-21,810 Reduced 47.97%	23,655 $26,000
Q2 2023 Aug 14, 2023	BUY	$1.04 - $1.4 $24,601 - $33,117	23,655 Added 108.46%	45,465 $51,000
Q2 2022 Aug 15, 2022	BUY	$0.67 - $1.4 $2,990 - $6,249	4,464 Added 25.74%	21,810 $29,000
Q1 2022 May 16, 2022	BUY	$1.23 - $3.31 $4,182 - $11,254	3,400 Added 24.38%	17,346 $21,000
Q4 2021 Feb 14, 2022	SELL	$2.89 - $4.43 $4,054 - $6,215	-1,403 Reduced 9.14%	13,946 $45,000
Q3 2021 Nov 15, 2021	BUY	$3.36 - $4.62 $2,483 - $3,414	739 Added 5.06%	15,349 $64,000
Q2 2021 Aug 16, 2021	BUY	$2.82 - $5.01 $41,200 - $73,196	14,610 New	14,610 $61,000

4.67M

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.